I’m conscious of these distinctions.
Statins decrease all trigger mortality. Statistically vital. Blue.
Threat ratio for a 0.5 mmol/l decrease LDL ldl cholesterol: 0.95 (0.92–0.99); p = 0.009
2 Likes
Within the absence of preexisting heart problems, statins don’t have any profit in main prevention to decrease all trigger mortality charges. This seems to be true even within the presence of different danger components.
It’s, nevertheless, fairly good for secondary prevention.
1 Like
Okay, fascinating dialogue.
I’ve now checked out all of the trials.
All had been about main prevention. And in 2 research of 11 had been there individuals included with pre-existing illness, however not solely (PROSPER and ASPEN). 9 of 11 trials had been completed with absence of preexisting heart problems.
Statins decrease all trigger mortality in main prevention. Even with out preexisting heart problems.
3 Likes
The load of the proof in favor of statins is so excessive in my view that it doesn’t even advantage additional discussions presently.
I see no hurt in taking them, in actual fact, fairly the alternative. It’s unlikely that any long-term, double-blind RCT goes to happen anytime quickly. Till that occurs and it proves statins should not helpful, I’ll fortunately carry on taking my each day dose of atorvastatin.
2 Likes
Absolute danger discount of complete mortality with statin utilization is of the order of 0.8% and might not be on account of its lipid discount.
1 Like
Right here’s a pleasant dialogue on how a lot absolute danger discount you’re getting out of it.
https://www.uspharmacist.com/article/statins-less-cv-risk-reduction-than-commonly-assumed
The ACM profit relies on the quantity of lipid discount, for each 0.5 mmol/L LDL discount a 5% decrease ACM.
So it’s exactly due to the lipid discount.
Additionally keep in mind these are brief time period trials. The MR and genetic research present a really giant lower in ASCVD associated occasions due to compounding advantages.
I feel you missed the purpose: “I see no hurt in taking them, in actual fact, fairly the alternative.”
Plus, my physician whom I respect, prescribed them, I didn’t ask for them.
I’m certain your heart specialist may be very competent. Merely stating absolute danger discount for functions of dialogue. Not making an attempt to diagnose or supply remedy recommendation.
It relies upon anyway on remedy length, background charge of occasions, stage of LDL discount, and so forth.
I’d suppose one benefit of statins can be a redirection of cytosolic metabolism in order that extra acetyl-CoA is out there for histone acetylation.
Certainly. Statins do behave as HDAC inhibitors which serves to extend histones acetylation and expression of p21 in human most cancers cells. Might be helpful in that regard as a most cancers fighter, however after all unrelated to lipids.
That’s an fascinating level. In the event that they solely inhibit HDAC2, nevertheless, then I’d suppose their impact on the provision of Acetyl-CoA is a minimum of related. The extent inhibition within the tens of micromolar shouldn’t be out of line with many different HDAC inhibitors though the large query is the bioavailability of anyone HDAC inhibitor.
Are you involved about acetyl Co A depletion with HDAC inhibition?
